These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6113614)

  • 1. Studies of prostaglandins and sulphasalazine in ulcerative colitis.
    Gould SR; Brash AR; Conolly ME; Lennard-Jones JE
    Prostaglandins Med; 1981 Feb; 6(2):165-82. PubMed ID: 6113614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ulcerative colitis: effect of sulphasalazine, its metabolites and indomethacin on the ability of human colonic mucosa to metabolize prostaglandins in vitro.
    Hillier K; Mason PJ; Pacheco S; Smith CL
    Br J Pharmacol; 1982 May; 76(1):157-61. PubMed ID: 6123357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin catabolism and ulcerative colitis: effect of sulphasalazine, 5-aminosalicylic acid and other drugs.
    Pacheco S; Hillier K; Smith CL
    Braz J Med Biol Res; 1990; 23(12):1323-34. PubMed ID: 1983789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.
    Lauritsen K; Hansen J; Bytzer P; Bukhave K; Rask-Madsen J
    Gut; 1984 Nov; 25(11):1271-8. PubMed ID: 6149981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assay of prostaglandin-like substances in faeces and their measurement in ulcerative colitis.
    Gould SR
    Prostaglandins; 1976 Mar; 11(3):489-97. PubMed ID: 948621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: Prostaglandins, ulcerative colitis, and sulphasalazine.
    Gould SR
    Lancet; 1975 Nov; 2(7942):988. PubMed ID: 53480
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostaglandin synthetase activity in acute ulcerative colitis: effects of treatment with sulphasalazine, codeine phosphate and prednisolone.
    Smith PR; Dawson DJ; Swan CH
    Gut; 1979 Sep; 20(9):802-5. PubMed ID: 40848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandins and mechanism of action of sulphasalazine in ulcerative colitis.
    Moore PK; Hoult JR; Laurie A
    Lancet; 1978 Jul; 2(8080):98-9. PubMed ID: 78320
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscle.
    Hoult JR; Moore PK
    Br J Pharmacol; 1980 Apr; 68(4):719-30. PubMed ID: 6103724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of sulphasalazine withdrawal on rectal mucosal function and prostaglandin E2 release in inactive ulcerative colitis.
    Rampton DS; Sladen GE
    Scand J Gastroenterol; 1981; 16(1):157-9. PubMed ID: 6112788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of colonic eicosanoid concentrations as predictors of relapse in ulcerative colitis: double blind placebo controlled study on sulphasalazine maintenance treatment.
    Lauritsen K; Laursen LS; Bukhave K; Rask-Madsen J
    Gut; 1988 Oct; 29(10):1316-21. PubMed ID: 2904392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the effect of sulphasalazine on the prostaglandin system and the defective prostaglandin inactivation observed in experimental ulcerative colitis.
    Hoult JR; Moore PK; Marcus AJ; Watt J
    Agents Actions Suppl; 1979; (4):232-44. PubMed ID: 40410
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostaglandins and sulphasalazine.
    Smith PR; Dawson DJ; Swan CH
    Lancet; 1978 Jul; 2(8083):260. PubMed ID: 79051
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism of sulphasalazine action in ulcerative colitis.
    Rachmilewitz D; Sharon P; Ligumsky M; Zor U
    Lancet; 1978 Oct; 2(8096):946. PubMed ID: 81963
    [No Abstract]   [Full Text] [Related]  

  • 15. Sulphasalazine is a potent inhibitor of prostaglandin 15-hydroxydehydrogenase: possible basis for therapeutic action in ulcerative colitis.
    Hoult JR; Moore PK
    Br J Pharmacol; 1978 Sep; 64(1):6-8. PubMed ID: 29685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of leucocyte motility by drugs used in ulcerative colitis.
    Rhodes JM; Bartholomew TC; Jewell DP
    Gut; 1981 Aug; 22(8):642-7. PubMed ID: 6116649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis.
    Lauritsen K; Laursen LS; Bukhave K; Rask-Madsen J
    Gut; 1987 Sep; 28(9):1095-9. PubMed ID: 2824300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.
    Sharon P; Ligumsky M; Rachmilewitz D; Zor U
    Gastroenterology; 1978 Oct; 75(4):638-40. PubMed ID: 30669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease: the in vitro effect of sulphasalazine and other agents on prostaglandin synthesis by human rectal mucosa.
    Pacheco S; Hillier K; Smith CL
    Braz J Med Biol Res; 1987; 20(2):221-30. PubMed ID: 2891390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study.
    Rao SS; Dundas SA; Holdsworth CD; Cann PA; Palmer KR; Corbett CL
    Gut; 1989 May; 30(5):675-9. PubMed ID: 2567266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.